Last Close
Feb 27  •  04:00PM ET
9.05
Dollar change
+0.04
Percentage change
0.44
%
Index- P/E- EPS (ttm)-0.78 Insider Own2.80% Shs Outstand682.00M Perf Week0.22%
Market Cap6.17B Forward P/E10.68 EPS next Y0.85 Insider Trans3.73% Shs Float662.99M Perf Month-18.10%
Enterprise Value9.94B PEG24.28 EPS next Q0.16 Inst Own100.52% Short Float6.01% Perf Quarter-23.63%
Income-530.20M P/S0.94 EPS this Y-12.35% Inst Trans-5.20% Short Ratio3.36 Perf Half Y-31.39%
Sales6.55B P/B1.11 EPS next Y7.41% ROA-4.44% Short Interest39.87M Perf YTD-21.03%
Book/sh8.16 P/C16.89 EPS next 5Y0.44% ROE-9.20% 52W High18.02 -49.78% Perf Year-45.12%
Cash/sh0.54 P/FCF12.47 EPS past 3/5Y- - ROIC-5.50% 52W Low8.80 2.84% Perf 3Y-62.79%
Dividend Est.- EV/EBITDA10.07 Sales past 3/5Y-4.46% 0.49% Gross Margin31.50% Volatility3.00% 4.09% Perf 5Y-67.53%
Dividend TTM- EV/Sales1.52 EPS Y/Y TTM-174.31% Oper. Margin8.80% ATR (14)0.43 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.18 Sales Y/Y TTM-3.41% Profit Margin-8.09% RSI (14)31.70 Recom2.86
Dividend Gr. 3/5Y- - Current Ratio1.78 EPS Q/Q-89.48% SMA20-8.62% Beta0.97 Target Price10.63
Payout0.00% Debt/Eq0.74 Sales Q/Q-1.36% SMA50-17.62% Rel Volume0.56 Prev Close9.01
Employees13500 LT Debt/Eq0.73 EarningsFeb 11 BMO SMA200-26.85% Avg Volume11.87M Price9.05
IPOMay 17, 2019 Option/ShortYes / Yes EPS/Sales Surpr.1.29% 1.61% Trades Volume6,659,986 Change0.44%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Downgrade Evercore ISI Outperform → In-line $12
Dec-17-25Downgrade Jefferies Hold → Underperform $9
Dec-15-25Downgrade BofA Securities Buy → Neutral $13
Nov-04-25Downgrade Raymond James Outperform → Mkt Perform
Oct-30-25Downgrade JP Morgan Overweight → Neutral $12
Oct-30-25Downgrade Barclays Overweight → Equal Weight $12
Aug-01-25Downgrade Jefferies Buy → Hold
Apr-29-25Downgrade Goldman Buy → Neutral $14
Apr-28-25Downgrade TD Cowen Buy → Hold $15.50
Apr-28-25Downgrade Stifel Buy → Hold $14
Feb-27-26 02:45PM
Feb-26-26 09:26AM
Feb-18-26 04:36AM
04:30AM
12:36AM
01:43AM Loading…
Feb-17-26 01:43AM
Feb-14-26 01:25AM
Feb-12-26 10:41AM
12:33AM
Feb-11-26 02:23PM
02:01PM
01:50PM
01:42PM
12:32PM
09:30AM
07:15AM Loading…
07:15AM
06:17AM
06:05AM
Feb-09-26 10:08PM
Feb-06-26 09:40AM
Feb-05-26 11:40AM
Feb-04-26 07:40AM
Feb-01-26 09:21AM
Jan-12-26 08:05AM
Jan-08-26 08:29AM
Jan-05-26 08:05AM
Jan-02-26 09:44AM
Jan-01-26 11:04PM
Dec-26-25 09:00AM
Dec-25-25 11:50PM
04:32AM Loading…
Dec-24-25 04:32AM
Dec-23-25 09:00AM
Dec-22-25 03:15AM
Dec-18-25 10:31PM
08:05AM
Dec-12-25 09:45AM
Dec-11-25 07:52AM
Dec-10-25 01:06PM
Dec-09-25 08:42AM
Dec-08-25 06:13AM
Dec-04-25 04:15PM
Nov-25-25 08:05AM
Nov-19-25 08:05AM
Nov-11-25 04:30AM
Nov-10-25 08:30AM
Nov-05-25 12:36AM
Nov-03-25 02:43AM
Oct-31-25 05:00PM
03:20PM
Oct-30-25 02:02PM
11:26AM
08:05AM
01:33AM
Oct-29-25 03:46PM
09:30AM
07:15AM
06:16AM
06:05AM
Oct-27-25 11:05PM
11:44AM
Oct-24-25 08:07AM
Oct-23-25 08:05AM
Oct-22-25 10:00AM
Oct-21-25 01:41PM
12:04AM
Oct-17-25 12:23PM
Oct-15-25 08:05AM
Oct-13-25 04:05PM
Oct-03-25 01:05PM
08:05AM
Oct-02-25 11:35PM
Oct-01-25 05:34PM
08:05AM
Sep-19-25 09:05AM
Sep-03-25 02:45PM
Aug-27-25 04:32PM
Aug-26-25 12:37AM
Aug-19-25 08:00AM
Aug-13-25 05:51PM
12:12AM
12:05AM
Aug-11-25 04:15PM
12:31PM
12:00PM
11:24AM
10:30AM
09:48AM
09:33AM
08:33AM
07:00AM
Aug-10-25 06:00PM
Aug-04-25 12:06PM
Aug-02-25 10:22AM
03:05AM
Aug-01-25 12:21PM
09:30AM
07:15AM
06:19AM
06:05AM
Jul-31-25 09:22AM
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the following geographical segments: the Americas, Europe, and AMEA. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUCIER GREGORY TDirectorFeb 19 '26Buy9.1650,000458,00050,000Feb 23 08:53 PM
SUMME GREGORY LDirectorFeb 12 '26Buy9.40100,000940,000400,000Feb 12 05:24 PM
MEHRA SANJEEV KDirectorDec 05 '25Buy11.09350,0003,881,500350,000Dec 09 05:11 PM
Ligner EmmanuelPresident and CEONov 17 '25Buy11.3587,500993,125283,424Nov 17 05:45 PM
Todd EdwardsofficerNov 06 '25Proposed Sale25.1629,131732,926Nov 06 04:26 PM
SUMME GREGORY LDirectorOct 30 '25Buy11.25100,0001,125,000300,000Oct 31 09:46 AM
SUMME GREGORY LDirectorAug 21 '25Buy12.56100,0001,256,000200,000Aug 22 04:15 PM
Eck Steven WSVP & Chief Accounting OfficerAug 05 '25Sale11.393,47639,59255,068Aug 06 04:32 PM
Eck Steven WOfficerAug 05 '25Proposed Sale11.393,47639,592Aug 05 10:58 AM
SUMME GREGORY LDirectorMay 23 '25Buy12.5030,000375,000100,000May 27 04:58 PM
SUMME GREGORY LDirectorMay 22 '25Buy12.6520,000253,00070,000May 22 05:37 PM
SUMME GREGORY LDirectorMay 07 '25Buy12.0025,000300,00050,000May 09 04:51 PM
Massaro Joseph RDirectorApr 29 '25Buy12.308,10099,63035,038Apr 29 05:58 PM
SUMME GREGORY LDirectorApr 28 '25Buy12.5025,000312,50025,000Apr 29 05:58 PM
Kang LanDirectorApr 28 '25Buy12.575,00062,85035,215Apr 29 05:58 PM
Peacock Jonathan MDirectorApr 28 '25Buy12.818,091103,646202,715Apr 29 05:58 PM
Last Close
Feb 27  •  04:00PM ET
14.68
Dollar change
+1.97
Percentage change
15.50
%
XRAY DENTSPLY Sirona Inc daily Stock Chart
Index- P/E- EPS (ttm)-3.00 Insider Own0.66% Shs Outstand199.55M Perf Week17.07%
Market Cap2.93B Forward P/E9.40 EPS next Y1.56 Insider Trans-5.24% Shs Float198.24M Perf Month19.25%
Enterprise Value5.03B PEG2.64 EPS next Q0.32 Inst Own102.32% Short Float7.42% Perf Quarter32.37%
Income-598.00M P/S0.80 EPS this Y-9.97% Inst Trans-3.77% Short Ratio3.50 Perf Half Y2.44%
Sales3.68B P/B1.98 EPS next Y8.46% ROA-10.70% Short Interest14.70M Perf YTD28.43%
Book/sh7.41 P/C8.99 EPS next 5Y3.56% ROE-36.44% 52W High19.03 -22.86% Perf Year-14.40%
Cash/sh1.63 P/FCF28.20 EPS past 3/5Y12.05% -51.27% ROIC-17.34% 52W Low9.85 49.04% Perf 3Y-57.51%
Dividend Est.0.18 (1.23%) EV/EBITDA8.31 Sales past 3/5Y-2.10% 1.95% Gross Margin57.07% Volatility6.50% 5.04% Perf 5Y-72.34%
Dividend TTM0.64 (4.36%) EV/Sales1.37 EPS Y/Y TTM-113.81% Oper. Margin6.88% ATR (14)0.67 Perf 10Y-75.80%
Dividend Ex-DateDec 26, 2025 Quick Ratio1.03 Sales Y/Y TTM-2.98% Profit Margin-16.25% RSI (14)68.64 Recom2.76
Dividend Gr. 3/5Y14.17% 10.99% Current Ratio1.51 EPS Q/Q66.18% SMA2013.59% Beta1.01 Target Price13.85
Payout- Debt/Eq1.81 Sales Q/Q6.19% SMA5018.74% Rel Volume3.21 Prev Close12.71
Employees14000 LT Debt/Eq1.57 EarningsFeb 26 AMC SMA2008.65% Avg Volume4.20M Price14.68
IPOAug 12, 1987 Option/ShortYes / Yes EPS/Sales Surpr.-2.70% 3.76% Trades Volume13,457,172 Change15.50%
Date Action Analyst Rating Change Price Target Change
Feb-19-26Upgrade BofA Securities Neutral → Buy $17
Dec-09-25Initiated Barclays Underweight $12
Nov-07-25Downgrade William Blair Outperform → Mkt Perform
Apr-15-25Downgrade Morgan Stanley Overweight → Equal-Weight $14
Mar-13-25Downgrade Needham Buy → Hold
Feb-14-25Initiated Wells Fargo Equal Weight $20
Jan-23-25Downgrade Jefferies Buy → Hold $30 → $20
Jan-07-25Downgrade Evercore ISI Outperform → In-line $20
Dec-04-24Initiated Mizuho Neutral $21
Nov-07-24Downgrade Leerink Partners Outperform → Market Perform
Feb-27-26 01:42PM
12:39PM
12:36PM
09:40AM
02:37AM
12:06AM Loading…
12:06AM
Feb-26-26 06:00PM
05:30PM
04:51PM
04:01PM
Feb-25-26 08:00PM
09:15AM
06:08AM
Feb-24-26 04:30PM
09:00AM
07:35AM Loading…
07:35AM
Feb-23-26 08:46AM
Feb-19-26 10:02AM
10:00AM
Feb-09-26 07:40AM
Feb-06-26 07:52PM
Feb-05-26 04:15PM
Feb-04-26 05:30PM
Jan-28-26 11:03PM
Jan-26-26 08:15AM
Jan-21-26 12:21PM
Jan-15-26 11:43AM
Jan-14-26 08:00AM
Jan-13-26 04:30PM
08:00AM
09:00AM Loading…
Jan-12-26 09:00AM
Jan-08-26 07:44AM
Jan-06-26 04:15PM
03:06PM
Dec-24-25 10:34PM
Dec-15-25 08:00AM
Dec-11-25 06:39AM
Nov-12-25 08:27PM
Nov-11-25 06:40AM
Nov-10-25 09:15AM
Nov-07-25 10:15AM
Nov-06-25 04:01PM
03:12PM
11:36AM
10:39AM
10:00AM
09:15AM
08:14AM
08:00AM
Nov-04-25 10:21PM
08:39AM
Oct-30-25 10:00AM
Oct-24-25 10:40AM
Oct-15-25 02:01PM
Oct-13-25 08:01AM
Oct-10-25 03:50PM
Oct-08-25 04:15PM
Oct-02-25 08:30AM
Sep-23-25 11:31PM
Sep-21-25 09:26PM
Sep-16-25 09:29AM
Sep-10-25 09:02AM
Sep-08-25 08:30AM
12:03AM
Aug-26-25 04:30PM
08:22AM
Aug-21-25 09:45AM
Aug-19-25 01:41PM
05:59AM
Aug-18-25 04:06AM
Aug-14-25 10:35AM
Aug-11-25 09:15AM
Aug-08-25 09:45AM
07:25AM
Aug-07-25 02:15PM
01:49PM
11:06AM
09:40AM
09:30AM
07:15AM
06:49AM
06:00AM
Aug-06-25 12:50PM
Aug-05-25 11:10PM
Aug-04-25 11:40AM
09:40AM
08:35AM
Jul-31-25 10:00AM
Jul-30-25 05:30PM
Jul-28-25 09:50AM
12:01AM
Jul-22-25 11:16AM
09:40AM
06:00AM
Jul-21-25 04:07PM
03:04PM
12:21PM
08:30AM
Jul-18-25 11:40AM
09:40AM
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUCIER GREGORY TDIRECTORDec 08 '25Proposed Sale11.1082,200912,420Dec 11 08:16 PM
LUCIER GREGORY TDirectorDec 08 '25Sale11.1482,200915,7080Dec 10 04:26 PM
VARON LESLIE FDirectorNov 24 '25Buy10.719,33799,99957,343Nov 25 05:26 PM
LUCIER GREGORY TDirectorMar 03 '25Buy16.5115,142249,99481,971Mar 03 06:33 PM
Last Close
Feb 27  •  04:00PM ET
3.56
Dollar change
0.00
Percentage change
0.00
%
MRVI Maravai LifeSciences Holdings Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.91 Insider Own28.83% Shs Outstand145.02M Perf Week14.84%
Market Cap910.32M Forward P/E- EPS next Y-0.14 Insider Trans0.77% Shs Float103.21M Perf Month4.09%
Enterprise Value1.22B PEG- EPS next Q-0.05 Inst Own77.30% Short Float10.61% Perf Quarter-5.32%
Income-130.77M P/S4.90 EPS this Y37.28% Inst Trans-1.74% Short Ratio9.35 Perf Half Y52.79%
Sales185.74M P/B2.10 EPS next Y24.90% ROA-11.40% Short Interest10.95M Perf YTD9.54%
Book/sh1.70 P/C3.74 EPS next 5Y24.47% ROE-41.06% 52W High4.11 -13.28% Perf Year16.72%
Cash/sh0.95 P/FCF- EPS past 3/5Y- - ROIC-21.84% 52W Low1.66 113.81% Perf 3Y-75.36%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-40.53% -8.15% Gross Margin17.33% Volatility4.81% 5.03% Perf 5Y-89.05%
Dividend TTM- EV/Sales6.57 EPS Y/Y TTM12.14% Oper. Margin-50.34% ATR (14)0.18 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.56 Sales Y/Y TTM-28.34% Profit Margin-70.41% RSI (14)61.98 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio5.29 EPS Q/Q-33.41% SMA2012.18% Beta0.38 Target Price4.33
Payout- Debt/Eq1.50 Sales Q/Q-11.59% SMA503.27% Rel Volume1.15 Prev Close3.56
Employees570 LT Debt/Eq1.44 EarningsFeb 25 AMC SMA20021.31% Avg Volume1.17M Price3.56
IPONov 20, 2020 Option/ShortYes / Yes EPS/Sales Surpr.43.02% 1.67% Trades Volume1,352,110 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-26-25Downgrade Robert W. Baird Outperform → Neutral $9 → $3
Dec-19-24Initiated Guggenheim Neutral
Dec-05-24Downgrade Goldman Neutral → Sell $4.25
Nov-14-24Initiated Wolfe Research Peer Perform
Nov-08-24Downgrade William Blair Outperform → Mkt Perform
Aug-28-24Initiated Wells Fargo Overweight $10
Aug-13-24Downgrade Morgan Stanley Overweight → Equal-Weight $11 → $10
Apr-10-24Initiated Craig Hallum Buy $15
Dec-12-23Upgrade BofA Securities Neutral → Buy $10 → $8
Aug-08-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-26-26 08:30AM
02:11AM
Feb-25-26 07:25PM
04:01PM
Feb-09-26 05:05PM
08:00AM Loading…
Nov-10-25 08:00AM
Nov-07-25 12:12AM
Nov-06-25 06:15PM
04:01PM
Nov-04-25 09:05AM
Oct-22-25 04:01PM
Aug-12-25 03:07AM
Aug-11-25 07:00PM
04:05PM
Jul-28-25 05:08PM
04:01PM Loading…
Jun-25-25 04:01PM
Jun-09-25 08:30AM
Jun-03-25 10:00AM
May-21-25 04:22PM
04:05PM
May-20-25 08:00AM
May-14-25 04:00PM
May-13-25 09:30AM
03:11AM
May-12-25 05:20PM
04:06PM
May-08-25 05:10PM
May-07-25 07:10PM
May-05-25 05:47AM
May-01-25 05:20PM
07:30AM Loading…
07:30AM
Apr-24-25 12:27PM
Apr-22-25 05:45AM
Apr-16-25 06:10PM
Apr-15-25 09:35AM
Apr-14-25 01:13PM
Apr-11-25 01:31PM
Apr-10-25 11:34AM
04:37AM
Apr-04-25 02:34PM
Apr-03-25 06:21PM
Apr-01-25 01:23PM
Mar-26-25 11:10AM
Mar-25-25 12:49PM
Mar-24-25 02:33PM
Mar-22-25 10:30AM
Mar-21-25 08:00PM
01:43PM
Mar-20-25 09:00PM
Mar-18-25 04:05PM
05:45AM
Mar-17-25 02:22AM
Mar-16-25 09:32AM
Mar-08-25 10:15AM
Feb-28-25 09:31AM
Feb-27-25 06:37PM
Feb-25-25 06:00AM
Feb-24-25 08:00AM
Feb-04-25 04:01PM
Feb-03-25 06:00AM
Jan-28-25 04:01PM
Jan-20-25 11:02PM
Jan-08-25 04:10PM
Dec-20-24 07:15AM
Dec-05-24 04:05PM
Nov-12-24 08:05AM
Nov-09-24 06:51AM
Nov-08-24 02:20PM
03:15AM
02:34AM
Nov-07-24 04:01PM
04:01PM
Oct-15-24 04:05PM
Oct-09-24 08:03AM
Sep-24-24 08:12AM
Aug-28-24 07:49AM
Aug-12-24 08:05AM
Aug-08-24 12:45AM
Aug-07-24 04:05PM
Jul-29-24 04:05PM
Jul-10-24 08:00AM
Jul-02-24 04:00PM
Jun-20-24 09:15AM
Jun-17-24 09:54AM
Jun-12-24 02:38AM
May-17-24 11:52AM
May-13-24 08:00AM
May-09-24 04:18PM
04:05PM
10:53AM
10:11AM
04:02AM
03:15AM
May-08-24 08:57PM
04:05PM
Apr-30-24 07:31AM
Apr-18-24 07:36AM
Apr-10-24 04:05PM
Mar-28-24 04:00PM
Mar-19-24 07:48AM
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRAHALAD MURALIFormer DirectorDec 23 '25Proposed Sale3.333,95113,138Dec 23 03:00 PM
Hopfield JessicaFormer DirectorDec 19 '25Proposed Sale3.4853,951187,526Dec 19 04:38 PM
LUCIER GREGORY TDirectorDec 05 '25Buy3.7051,472190,446106,595Dec 09 04:36 PM
LUCIER GREGORY TDirectorDec 08 '25Buy3.6748,528178,098155,123Dec 09 04:36 PM
Brust BerndChief Executive OfficerNov 13 '25Buy3.25216,212702,689466,771Nov 17 04:48 PM
Brust BerndChief Executive OfficerNov 11 '25Buy3.24157,201509,331157,201Nov 13 05:27 PM
Brust BerndChief Executive OfficerNov 12 '25Buy3.2193,358299,679250,559Nov 13 05:27 PM